Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Email Solicitation For Pricing Strategy Triggered DOJ Investigation – Zimmer

This article was originally published in The Gray Sheet

Executive Summary

An email from an orthopedic manufacturer that solicited competitors to adopt a "uniform pricing strategy" for a hospital triggered recent Department of Justice (DOJ) antitrust investigations, according to Zimmer

You may also be interested in...



Ortho Industry Reaches $311 Mil. Settlement With DoJ On Kickback Charges

Four major hip and knee implant manufacturers will pay the government a total of $311 million to settle anti-kickback claims resulting from a two-year Department of Justice and HHS investigation into the companies' financial relationships with surgeons, the New Jersey U.S. Attorney's office announced Sept. 27

Ortho Industry Reaches $311 Mil. Settlement With DoJ On Kickback Charges

Four major hip and knee implant manufacturers will pay the government a total of $311 million to settle anti-kickback claims resulting from a two-year Department of Justice and HHS investigation into the companies' financial relationships with surgeons, the New Jersey U.S. Attorney's office announced Sept. 27

DoJ Probes Big Orthopedic Firms’ Pricing, Deflating Investor Confidence

The U.S. Department of Justice served subpoenas to the five largest orthopedic manufacturers to investigate suspected industry violations of antitrust laws in pricing hip and knee implants. The specific nature of the inquiry is unknown

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel